Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00314691
NCT00314691
Terminated
Not Applicable

Development of New Prenatal Diagnostic Tests From Maternal Blood

University Hospital, Strasbourg, France1 site in 1 country10 target enrollmentApril 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHereditary Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hereditary Diseases
Sponsor
University Hospital, Strasbourg, France
Enrollment
10
Locations
1
Primary Endpoint
Feasibility of fetal gender and genotype determination out of maternal blood
Status
Terminated
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
September 2006
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France

Eligibility Criteria

Inclusion Criteria

  • •Mother and father-to-be both older than 18 years old
  • •Mother and father-to-be affiliated to social security
  • •Mother and father-to-be have good understanding of the protocol
  • •Pregnancy of the mother-to-be attested

Exclusion Criteria

  • •Mother and father-to-be are younger than 18 years old
  • •Mother and/or father-to be refusing to participate

Outcomes

Primary Outcomes

Feasibility of fetal gender and genotype determination out of maternal blood

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Non-invasive Prenatal Diagnostic Validation StudyChromosome 13 AneuploidyChromosome 18 AneuploidyChromosome 21 AneuploidySex Chromosome AberrationsOther Microdeletions
NCT01574781Natera, Inc.1,781
Completed
Not Applicable
A Safer Pre-Natal Diagnosis Using Free DNA in Maternal BloodAneuploidy, NIPT
NCT01472523Premaitha Health1,632
Completed
Not Applicable
Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic TestingPregnancy Following IVF With PGS/PGD
NCT01546324Natera, Inc.16
Completed
Not Applicable
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal BloodTrisomy 21Trisomy 18Trisomy 13Sex Chromosome AbnormalitiesMicrodeletion Syndromes
NCT01852708Natera, Inc.1,059
Unknown
Not Applicable
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal BloodChromosome Disorders
NCT00064597Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,500